75A50124F61009↗
Seqirus Inc received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $396.0K obligated so far for drugs and biologicals. It runs to 2027-05-21.
Key facts · data as of Oct 25, 2026
- Recipient
- Seqirus Inc
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $396.0K
- Potential value
- $396.0K
- Ends
- 2027-05-21
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75A50124F61009, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75A50124F61009_7505_75A50122D00004_7505
Seqirus Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
Up for re-bid: ends 2027-05-21. Recompete brief →
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75A50122D00004
- Where the work is
- Wake, NC · district NC-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
8 actions since 2024-02-21. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-01 | P00007 | Option exercised | $126.2K | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| 2026-02-02 | P00006 | Administrative change | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| 2026-01-22 | P00005 | Administrative change | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| 2025-06-11 | P00004 | Administrative change | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| 2025-02-18 | P00003 | Option exercised | $152.3K | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| 2024-11-05 | P00002 | Administrative change | $0 | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO MAKE ADMINISTRATIVE CORRECTIONS TO THE CLIN NUMBERING AND THE START YEAR FOR OPTION PERIOD 4 IN SECTION B.2 AND THE ENDING DATE FOR OPTION 1 IN SECTION F.1 PERIOD OF PERFORMANCE. IN ADDITION, CHANGE TH |
| 2024-04-22 | P00001 | Option exercised | $88.2K | -2/21/2025. 2. REVISE THE POP OF OPTION PERIOD 1 FROM 5/22/2024 - 5/21/2025 (12-MONTHS) TO 5/22/2024 - 2/21/2025 (9-MONTHS). OPTION PERIOD 1 DECREASED BY $30,270.00 FROM $118,425.00 TO $88,155.00. 3. ADD OPTION PERIOD 4 WITH A POP FROM 2/22/20 |
| 2024-02-21 | 0 | $29.4K | THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗